Tamoxifen Therapy for Ovarian Cancer in the Adjuvant and Advanced Settings: Systematic Review of the Literature and Implications for Future Research
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (2) , 201-209
- https://doi.org/10.1006/gyno.2001.6489
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell lineInternational Journal of Cancer, 1998
- Tamoxifen in the Treatment of Recurrent Ovarian CarcinomaInternational Journal of Gynecologic Cancer, 1997
- Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary ReportGynecologic Oncology, 1996
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of TreatmentJNCI Journal of the National Cancer Institute, 1994
- Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesInternational Journal of Cancer, 1993
- Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursEuropean Journal Of Cancer, 1992
- Estrogen and Anti-Estrogen Effects on the Growth of Human Epithelial Ovarian Cancer In VitroObstetrics & Gynecology, 1989
- A phase II study of tamoxifen in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- 216 Treatment of advanced ovarian carcinoma with tamoxifen. a phase II trialJournal of Steroid Biochemistry, 1983
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975